Oral Minoxidil in NZ: Evidence, Side Effects, and Topical Compared

Minoxidil has been the workhorse of hair-loss treatment for forty years. For most of that time it meant a sticky liquid you rubbed on your scalp twice a day — messy, fiddly, hit-and-miss adherence. In the last five years, low-dose oral minoxidil has quietly taken over, and a lot of NZ men are switching without realising the choice is more nuanced than "oral is just easier".

This post walks through both, when each works best, and what the practical NZ picture looks like.

What minoxidil actually does

Minoxidil was originally a blood-pressure medication. The hair-growth side effect was discovered by accident. Mechanism in the scalp: it shortens the resting (telogen) phase of the hair cycle, lengthens the growing (anagen) phase, and increases the calibre of follicles that are still alive.

It does not regrow hair from dead follicles. Realistic expectation: it slows further loss and gives you slightly thicker, slightly denser regrowth on follicles that haven't fully miniaturised yet.

Topical minoxidil — the original

Standard dosing: 5% solution or foam, applied to a dry scalp twice daily. Two to three squirts each time, massaged in.

Pros:

• Stays in the scalp where you want it. Minimal systemic absorption.
• Pharmacy-only in New Zealand at up to 5% — no prescription needed, but it is sold through a pharmacy.
• Side-effect profile is mild — mostly local: dryness, itch, occasional contact dermatitis.

Cons:

• Adherence is the killer. Studies show most men stop within 12 months. Twice-daily for life is a big ask.
• The solution makes hair feel greasy or stiff. Foam is better but more expensive.
• Skin contact transfer — keep away from children and pets.
• Has to be reapplied to wet hair after every wash, swim or sweaty session.

Best for: men starting medical hair-loss treatment, men who don't want any systemic effects, men who tolerate the routine.

Oral minoxidil — the rising option

Dosing: the doses used for hair loss are a small fraction of the blood-pressure dose the tablet is registered at — the only oral minoxidil product registered in New Zealand is a 10 mg tablet, indicated for severe refractory hypertension, with a usual adult range of 5–40 mg a day. Because hair loss is an off-label use there is no NZ-approved dosing schedule for it, and the international consensus below explicitly failed to reach agreement on titration. Any dose is a matter for the prescriber who is monitoring you.

Pros:

• One pill, once a day. Adherence is dramatically better.
• Works systemically — covers the whole scalp, not just where you remember to apply it.
• How it compares with 5% topical head-to-head is still an open question — the consensus statement below lists that comparison as a priority for future research.
• A 2025 international Delphi consensus in JAMA Dermatology supported low-dose oral minoxidil as an option where topical fails or isn't tolerated. That is expert consensus, not trial evidence.

Cons:

• Common side effects: facial hypertrichosis (mild extra hair growth on face — usually settles or becomes background), mild fluid retention, lightheadedness on standing if dose is too high.
• Less commonly: tachycardia, ankle oedema. Both dose-related.
• Not for men with significant cardiac history, severe hypertension, or those on multiple antihypertensives — needs a doctor's review first.
• Not funded by PHARMAC for hair loss — it is a private cost.
• Requires a prescription. It's a real medication, not a cosmetic.

Best for: men who've tried topical and stopped, men with crown loss (where topical struggles), men who want simpler routines, men under 60 without significant cardiac comorbidities.

What about combining both?

Some clinicians use low-dose oral plus topical, especially in the first 6–12 months of aggressive treatment. The combination is more effective than either alone but doubles the side-effect risk to monitor. Worth discussing if your hair loss is rapid and you want the strongest medical-only approach.

Side-effect monitoring on oral minoxidil

Low-dose oral minoxidil for hair loss is an off-label use in New Zealand — the registered indication for oral minoxidil is hypertension. Where a prescriber does use it, the monitoring that matters is:

• Resting heart rate (baseline + at 4 weeks)
• Blood pressure (baseline + at 4 weeks if any history of hypertension)
• Ankle swelling (self-reported)
• New facial hair (cosmetic only — bothers some men, fine for others)

Most side effects emerge within the first 6 weeks if they're going to. If you're stable at 8 weeks, you're likely stable long-term.

When to switch from topical to oral

Common reasons:

• You've used topical consistently for 12 months and still seeing progression
• You're not actually using it consistently (be honest)
• Crown loss is the main issue — topical struggles there
• You hate the routine

Switching is a prescriber's decision — the sequencing, and the monitoring that goes with it, get set by whoever is prescribing.

When NOT to switch

Stay on topical if:

• You have cardiac disease or are on multiple BP medications
• You've had any reaction to systemic vasodilators
• You're under 25 (limited long-term data on oral minoxidil at this age — case-by-case)
• You can't tolerate the idea of slight facial hair (rare but possible)

What to do next

If you're on topical and it's working, don't fix what isn't broken. If you're not using it consistently, that's worth raising with a doctor — adherence is one of the things a prescriber weighs when discussing whether a different route suits you. Oral use for hair loss is off-label in New Zealand, so it needs an individual assessment rather than being a default next step.

Either way, the medical decision benefits from a NZ-registered doctor reviewing your case before you commit.

One thing worth knowing if surgery is on your mind: minoxidil has its own early shedding phase, which can overlap with the post-transplant shed and make weeks three to eight look considerably worse than they really are. Starting or changing minoxidil around the time of a procedure is worth timing deliberately with your prescriber — see FUE recovery week by week for what the post-transplant shed looks like.

Sources cited:

• DermNet NZ — Minoxidil for hair loss: https://dermnetnz.org/topics/minoxidil-solution
• BPAC NZ — Male pattern hair loss in primary care
• Akiska YM, Mirmirani P, Roseborough I, et al. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement. JAMA Dermatol. 2025;161(1):87–95: https://jamanetwork.com/journals/jamadermatology/article-abstract/2826573
• NZ Formulary — Minoxidil monograph
• Medsafe NZ — Minoxidil data sheet

This article is general information, not medical advice. If you're considering changing your hair-loss medication, talk to an NZ-registered doctor about your specific situation.